Home Privacy Archive Realtime Report

Stock Trading History of Kaye Randall

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kaye Randall since year 2005. The trader's CIK number is 1350416. At the time of this reporting, Kaye Randall is the Chief Medical Officer of Avanir Pharmaceuticals (stock ticker symbol AVN).

Stock purchases, sales, and option exercises reported by *Kaye Randall* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2006-05-08	AVNR	Avanir Pharmaceuticals	Option Exercise	12,500	.04	500
2006-05-26	AVNR	Avanir Pharmaceuticals	Purchase	2,500	9.96	24,893

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kaye Randall (Chief Medical Officer of Avanir Pharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.